Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell‐cycle control

The mammalian SWI/SNF chromatin remodeling complex is becoming increasingly recognized for its role in tumor suppression, based on its ability to regulate accessibility of proliferation‐associated genes to transcription factors. However, understanding the biological role of the complex is complicated because the same complex seemingly plays both positive and negative roles in gene expression. Work described here reveals that a choice between two independently encoded, closely related variants of a major subunit of the ARID protein family determines whether the SWI/SNF complex forms further associations with activator versus repressor complexes. The choice distinguishes assemblies with opposite effects on cell‐cycle activity. The specific complexes control access of factors such as E2F1, Tip60, and HDAC1/2/3 to the promoters of various cell‐cycle‐specific genes, with c‐Myc emerging as a particularly critical target.

[1]  R. Roberts,et al.  Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products , 1987, Molecular and cellular biology.

[2]  C. Verrijzer,et al.  Composition and functional specificity of SWI2/SNF2 class chromatin remodeling complexes. , 2005, Biochimica et biophysica acta.

[3]  Da-Wei Liao,et al.  Monoclonal antibodies reactive with the BAF155 (SMARCC1) and BAF170 (SMARCC2) components of human SWI/SNF-related complexes. , 2005, Hybridoma.

[4]  J. Biegel.  Molecular genetics of atypical teratoid/rhabdoid tumor. , 2006, Neurosurgical focus.

[5]  J. Nevins,et al.  Temporal Control of Cell Cycle Gene Expression Mediated by E2F Transcription Factors , 2005, Cell cycle.

[6]  D. Reinberg,et al.  ING 1 Candidate Tumor Suppressor p 33 Complex in Growth Regulation by the Role of the Sin 3-Histone Deacetylase , 2001 .

[7]  S. Cohen,et al.  Osa modulates the expression of Apterous target genes in the Drosophila wing , 2004, Mechanisms of Development.

[8]  D. Levy,et al.  New and Old Functions of STAT3: A Pivitol Target for Individualized Treatment of Cancer , 2005, Cell cycle.

[9]  K. Helin,et al.  E2F target genes: unraveling the biology. , 2004, Trends in biochemical sciences.

[10]  Stuart H. Orkin,et al.  The SWI/SNF complex — chromatin and cancer , 2004, Nature Reviews Cancer.

[11]  D. Reinberg,et al.  RBP1 Recruits the mSIN3-Histone Deacetylase Complex to the Pocket of Retinoblastoma Tumor Suppressor Family Proteins Found in Limited Discrete Regions of the Nucleus at Growth Arrest , 2001, Molecular and Cellular Biology.

[12]  M. Yaniv,et al.  SWI/SNF chromatin remodeling and cancer. , 2002, Current opinion in genetics & development.

[13]  P. Dallas,et al.  The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest. , 2005, Cancer research.

[14]  Jerry L. Workman,et al.  ATP-Dependent Chromatin-Remodeling Complexes , 2000, Molecular and Cellular Biology.

[15]  Steven P. Angus,et al.  Hierarchical Requirement of SWI/SNF in Retinoblastoma Tumor Suppressor-mediated Repression of Plk1* , 2004, Journal of Biological Chemistry.

[16]  R. Kingston,et al.  Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. , 2001, Genes & development.

[17]  Yigong Shi,et al.  Transforming Growth Factor (cid:2) -Mediated Transcriptional Repression of c- myc Is Dependent on Direct Binding of Smad3 to a Novel Repressive Smad Binding Element , 2022 .

[18]  T. Yeatman,et al.  Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  N. Dyson,et al.  Molecular mechanisms of E2F-dependent activation and pRB-mediated repression , 2004, Journal of Cell Science.

[20]  David M. Livingston,et al.  E2F-Dependent Histone Acetylation and Recruitment of the Tip60 Acetyltransferase Complex to Chromatin in Late G1 , 2004, Molecular and Cellular Biology.

[21]  J. Torchia,et al.  A Novel Nuclear Receptor Corepressor Complex, N-CoR, Contains Components of the Mammalian SWI/SNF Complex and the Corepressor KAP-1* , 2000, The Journal of Biological Chemistry.

[22]  G. Stein,et al.  Transcriptional control of osteoblast growth and differentiation. , 1996, Physiological reviews.

[23]  J. Nevins,et al.  E2Fs link the control of G1/S and G2/M transcription , 2004, The EMBO journal.

[24]  M Lipp,et al.  E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Hirano,et al.  Stat3 Is Required for the Gp130-mediated Full Activation of the C-myc Gene , 1999 .

[26]  M. Schwab,et al.  Genomic instability in Ip and human malignancies , 1996, Genes, chromosomes & cancer.

[27]  Karl Ekwall,et al.  Sin3: a flexible regulator of global gene expression and genome stability , 2004, Current Genetics.

[28]  J. Biegel.  Molecular genetics of atypical teratoid/rhabdoid tumors , 2006 .

[29]  P. Dallas,et al.  p300/CREB Binding Protein-Related Protein p270 Is a Component of Mammalian SWI/SNF Complexes , 1998, Molecular and Cellular Biology.

[30]  E. Seto,et al.  Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression. , 2003, Current opinion in genetics & development.

[31]  L. Quarles,et al.  Distinct proliferative and differentiated stages of murine MC3T3‐E1 cells in culture: An in vitro model of osteoblast development , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  P. Dallas,et al.  Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. , 2004, The Biochemical journal.

[33]  W. El-Deiry,et al.  Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[34]  Andrea Cocito,et al.  Genomic targets of the human c-Myc protein. , 2003, Genes & development.

[35]  Joseph R. Nevins,et al.  Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F , 1997, Nature.

[36]  P. Dallas,et al.  Expression of p270 (ARID1A), a component of human SWI/SNF complexes, in human tumors , 2004, International journal of cancer.

[37]  C. Allis,et al.  An activity gel assay detects a single, catalytically active histone acetyltransferase subunit in Tetrahymena macronuclei. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Farnham,et al.  The Chromatin Structure of the Dual c-myc Promoter P1/P2 Is Regulated by Separate Elements* , 2001, The Journal of Biological Chemistry.

[39]  J. Massagué,et al.  E2F4/5 and p107 as Smad Cofactors Linking the TGFβ Receptor to c-myc Repression , 2002, Cell.

[40]  Brian David Dynlacht,et al.  E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. , 2002, Genes & development.

[41]  G. Beck,et al.  Gene array analysis of osteoblast differentiation. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[42]  M. Rosenfeld,et al.  REST Repression of Neuronal Genes Requires Components of the hSWI·SNF Complex* , 2002, The Journal of Biological Chemistry.

[43]  D. King,et al.  Largest Subunits of the Human SWI/SNF Chromatin-remodeling Complex Promote Transcriptional Activation by Steroid Hormone Receptors* , 2002, The Journal of Biological Chemistry.

[44]  E. Moran,et al.  DNA-binding properties of ARID family proteins , 2005, Nucleic acids research.

[45]  A. Blais,et al.  Hitting their targets: an emerging picture of E2F and cell cycle control. , 2004, Current opinion in genetics & development.

[46]  F. Winston,et al.  Recent advances in understanding chromatin remodeling by Swi/Snf complexes. , 2003, Current opinion in genetics & development.

[47]  Takeshi Shimamura,et al.  The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy. , 2006, Neurosurgical focus.

[48]  M. Roussel,et al.  Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. , 1994, Oncogene.

[49]  E. Moran,et al.  Nomenclature of the ARID family of DNA-binding proteins. , 2005, Genomics.